phm4153 cream formulation
DESCRIPTION
cream formulationTRANSCRIPT
Cream Formulation
Kausar AhmadKulliyyah of Pharmacy
http://staff.iiu.edu.my/akausar/PHM4153
PHM4153 Dosage Design 2 2009/10
Contents
Ideal formulation
Types of excipients
Functions
Factors for consideration
PHM4153 Dosage Design 2 2009/10
Every medicinal product is a combination of the
drug substance and excipients.
Knowledge of the composition, function, and
behavior of excipients is a prerequisite to the
successful design, development and
manufacture of pharmaceutical dosage forms.
PHM4153 Dosage Design 2 2009/10
Formulation
Process whereby drugs are combined with other substances (excipients)
BindersFillersPreservatives etc.
to produce dosage formsOral (liquid, solid)Parenteral (IV, aqueous or oily injections)Rectal (suppositories, aerosols)Topical (cream, ointment, lotion)
suitable for administration to or by patients.
PHM4153 Dosage Design 2 2009/10
Excipients
Other components other than ACTIVE
ingredient/s intentionally added
to…….formulation
PHM4153 Dosage Design 2 2009/10
Ideal formulation
Non-irritant
Non-allergenic
Non-staining
Easy to apply
Pleasant feeling to
the skin
Non-toxic
Non-harmful
Incapable of microorganism growth
Free from side-effects
PHM4153 Dosage Design 2 2009/10
Requirement of formulation efficacy, safety, and quality
Contain an accurate dose Be convenient to take or administer Provide the drug in a form for absorption or other
delivery to the target Retain quality throughout the shelf life and usage
period Be manufactured by a process that does not
compromise performance and that is reproducible and economical
PHM4153 Dosage Design 2 2009/10
Factors to be considered in formulation
Physicochemical properties
Choice of vehicle
Waxes and oils or emulsions
Categories of excipients
Provide essential part of the dosage form
Prevent degradation of the formulation
Stability
PHM4153 Dosage Design 2 2009/10
Physicochemical Properties
Oils susceptible to oxidation
Incorporate antioxidants
E.g. BHT, BHA
Aqueous solutions support microbial growth
Incorporate water-soluble preservatives
E.g. methyl and propyl paraben
BUT these may affect the endocrine…..
PHM4153 Dosage Design 2 2009/10
Examples of Creams Whitening
Benzophenone, Hydroquinone Herbal-based (fair & lovely) Pearl Fruit extracts (olay, estee)
Anti-ageing Collagen, seaweed extract (Imedeen) liposome
Virility Active: fish & herbs (2 types) Excipients: aromatic emollient, Vitamin E, D-
panthenol
PHM4153 Dosage Design 2 2009/10
Bases for Creams
Bases from mixtures of low and high
MW PEG
Liposomes
Microemulsions
Multiple emulsions
Fluorocarbon emulsions – ultra low i
PHM4153 Dosage Design 2 2009/10
Functions of excipients
Aid processing during manufacturing
Protect, support, or enhance stability and
bioavailability
Assist product identification colour
Improve effectiveness and safety of product
during storage or use
QExample?
PHM4153 Dosage Design 2 2009/10
Choice of excipients
physiological inertness
physical and chemical stability
conformance to regulatory agency requirements
no interference with drug bioavailability
absence of pathogenic microbial organisms
commercially available at low cost
PHM4153 Dosage Design 2 2009/10
Limitation in choice of excipients
no single excipient would satisfy all the criteria;
therefore, a compromise of the different
requirements has to be made.
For example, although widely used in pharmaceutical tablet
and capsule formulations as a diluent, lactose may not be
suitable for patients who lack the intestinal enzyme lactase
to break down the sugar, thus leading to the gastrointestinal
tract symptoms such as cramps and diarrhea.
PHM4153 Dosage Design 2 2009/10
Categories of excipients Provide essential parts of dosage form
Emulsifiers
Suspending agents
Gelling agents
Binders
Prevent degradation of the formulationAnti-oxidants
Anti-bacterials
Preservatives
UV absorbers
PHM4153 Dosage Design 2 2009/10
Excipients in CREAMS
Bases….. SAA
Anionic - SDSNon-ionic – Span,
Tween Anti-oxidants – BHA, BHT Preservatives: methyl and
propyl paraben (potency, integrity, prevent microbial growth)
Stearic acid
Stearyl alcohol, cetyl
alcohol
Glycerol monostearate
Lanolin
Glycerin
Zinc stearate
opacifying agent,
dusting powder…..
PHM4153 Dosage Design 2 2009/10
Microstructural properties of creams
texture and consistency is determined by the phase
behaviour of the component emulsifiers.
Rheological, thermal and microscopical means
characterise the physico-chemical properties
X-ray diffraction data
PHM4153 Dosage Design 2 2009/10
Effect of carrier on drug delivery
Must not interact with active substance
Control rate of release from vehicle…
What are the delivery systems?
Alter stratum corneum resistance……
Physical? Chemical?
Enhance stratum corneum hydration…..
PHM4153 Dosage Design 2 2009/10
Delivery systems (in cosmetics)
Vesicular
liposomes & niosomes
Molecular
cyclodextrin
Particulate
Microcapsules, matrix
particles
Encapsulation
Why?
PHM4153 Dosage Design 2 2009/10
Excipients as Penetration enhancers
Increase delivery of active substance
1. Disturb packing of SC lipid bilayers…..
Examples: Sulfoxides, alcohols, polyols, alkanes, esters,
amines/amides of fatty acids, terpenes, surfactants,
cyclodextrins
2. disruption of skin barrier
Extraction of skin lipids with apolar solvents e.g. acetone
Physical stripping
Physically or chemically induced irritation
PHM4153 Dosage Design 2 2009/10
Effect of type of preparationAbsorption of retinyl palmitate
18% absorbed from acetone vehicle
compared to only
4% absorbed from o/w emulsion
Q What is the mechanism of absorption?
PHM4153 Dosage Design 2 2009/10
Excipients for hydration
Hygroscopic effect of NaCl, sorbitol,
polypropylene glycol, glycerol
Low MW glycerols alter water-binding capacity
of corneocytes
Urea not for < 5 years old
Gives moisturising effect
Types
PHM4153 Dosage Design 2 2009/10
PHM4153 Dosage Design 2 2009/10
PHM4153 Dosage Design 2 2009/10
Physical and chemical propertiesof excipients
solubility
hygroscopicity
swelling
hydration capacity
particle size distribution
bulk density, tap density
specific surface area
complexation
infrared spectrum
microbes
PHM4153 Dosage Design 2 2009/10
Polyamide – an excipient
Carrier for insoluble ingredientsProtector for sensitive ingredientsSlow delivery & long lasting effect
10 m, porous 7 m, empty spheres
20 m
Pore volume distribution of porous polyamide particles
PHM4153 Dosage Design 2 2009/10
PHM4153 Dosage Design 2 2009/10
Incompatibility
PhysicalImmiscibilit
y
insolubility
ChemicalpH effects – dissociation?
pH and disperse systems
Soap emulsions and polyvalent
cations
Complexation
Cationic and anionic
compounds of high MW
Reducing agents (cause fading
of dyes)
PHM4153 Dosage Design 2 2009/10
Drug type and pH of medium
pHbasic
acidic
neutral
DrugPromethazine
Chlorhexidine
Ibuprofen
Fentiazac
Piroxicam
Fluorouracil
Crotamiton
Hydrocortisone acetate
PHM4153 Dosage Design 2 2009/10
Incompatibility
Formulation and packaging materials
E.g. softening of plastic containers by methyl
salicylate ointment.
Q What reaction occurs?
PHM4153 Dosage Design 2 2009/10
Detection of Incompatibility
Cracked cream
Hydrolysis or oxidation ….visual..?
Discoloration
Precipitation
PHM4153 Dosage Design 2 2009/10
Emulsifying Wax BP
Incorporation of anionic emulgent resulted
in the following:
Crack
Hinder release of cationic medicaments
Lower the antimicrobial activity of a cationic
medicament or preservative.
PHM4153 Dosage Design 2 2009/10
Cationic compounds
1. Tertiary ammonium compounds Cetrimide
Cetylpyridinium chloride
Benzalkonium salts
Domiphen bromide
2. Chlorhexidine salts
3. Dequalinium salts
4. Acridines
5. Triphenylmethane dyes
6. Neomycin sulphate
PHM4153 Dosage Design 2 2009/10
Exercise: Determine functions of excipients
Nizoral cream Ketoconazole PPG Steary alcohol Cetyl alcohol Sorbitan stearate Polysorbate Isopropyl myristate Sodium sulfite Purified water
Elomet cream 0.1% Mometasone furoate White petrolatum White wax PPG stearate Stearyl alcohol Ceteareth-20 Hexylene glycol Titanium dioxide Al starch octenylsuccinate Purified water Phosphoric acid - pH
PHM4153 Dosage Design 2 2009/10
References
1. http://www.eastman.com/Markets/Pharmaceutical/Excipients/Excipients_intro.asp
2. http://www.pharmaceutical-technology.com/contractors/materials/uniqema/
3. http://www.pformulate.com/
4. http://images.vertmarkets.com/CRLive/files/Downloads/89FB7970-7376-44A0-B6B6-4B171E4B978B/InsolubleKollidon.pdf